drug development
Why haven't we eradicated more diseases?: Pharma incentives
The subscription model I spent twelve years in drug development before I switched to policy. I didn’t leave because the science was bad. I left because I finally understood what the science was for. The pharmaceutical industry’s R&D pipeline optimizes for return on investment....